NTPDase8

NTPDase8 (ENTPD8) is a plasma membrane ectonucleotidase that hydrolyzes extracellular nucleoside triphosphates and diphosphates, thereby regulating nucleotide availability in purinergic signaling pathways^[1][2]. As one of the four cell-surface NTPDase isoforms, NTPDase8 contains two transmembrane domains and an extracellular catalytic region that controls ATP and ADP turnover in the extracellular environment^[1]. Mechanistically, extracellular nucleotide hydrolysis by NTPDase8 influences P2 receptor activation and contributes to the balance between pro-inflammatory nucleotide signaling and downstream purinergic responses^[1][3]. Biochemical studies demonstrated that NTPDase8 efficiently hydrolyzes ATP and UTP and displays enzymatic properties distinct from other plasma membrane NTPDases, resulting in differential regulation of P2Y and P2X receptor signaling^[3][4]. Compared with NTPDase1, which rapidly hydrolyzes both ATP and ADP, NTPDase8 permits transient accumulation of ADP during ATP hydrolysis, indicating a distinct capacity to modulate ADP-sensitive purinergic receptors^[3]. Disease-oriented studies further showed that NTPDase8 attenuates experimental colitis and protects against intestinal inflammation through regulation of nucleotide-dependent inflammatory pathways involving P2X4- and P2Y6-associated signaling mechanisms^[5][6]. These findings identify NTPDase8 as a regulator of mucosal immune homeostasis and intestinal inflammatory responses^[5][6]. For experimental applications, comparative enzymology studies have established NTPDase8 as a useful model for investigating isoform-specific control of extracellular nucleotide metabolism and receptor activation^[3][4]. Limited evidence currently supports the use of selective NTPDase8-targeted pharmacological agonists or inhibitors, although ENTPDases as a family remain of interest for therapeutic modulation of purinergic signaling^[1].